DK1032429T3 - Fremgangsmåde til DNA-afgivelse in vivo ved anvendelse af et nålefrit apparatur - Google Patents

Fremgangsmåde til DNA-afgivelse in vivo ved anvendelse af et nålefrit apparatur

Info

Publication number
DK1032429T3
DK1032429T3 DK98962403T DK98962403T DK1032429T3 DK 1032429 T3 DK1032429 T3 DK 1032429T3 DK 98962403 T DK98962403 T DK 98962403T DK 98962403 T DK98962403 T DK 98962403T DK 1032429 T3 DK1032429 T3 DK 1032429T3
Authority
DK
Denmark
Prior art keywords
needle
protein
free apparatus
vivo
mammal
Prior art date
Application number
DK98962403T
Other languages
English (en)
Inventor
Lorne Erdile
Jean Haensler
Original Assignee
Aventis Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur filed Critical Aventis Pasteur
Application granted granted Critical
Publication of DK1032429T3 publication Critical patent/DK1032429T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
DK98962403T 1997-11-20 1998-11-20 Fremgangsmåde til DNA-afgivelse in vivo ved anvendelse af et nålefrit apparatur DK1032429T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97120384 1997-11-20
PCT/EP1998/007812 WO1999026662A1 (en) 1997-11-20 1998-11-20 A method for in vivo dna delivery using a needle free apparatus

Publications (1)

Publication Number Publication Date
DK1032429T3 true DK1032429T3 (da) 2003-09-22

Family

ID=8227650

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98962403T DK1032429T3 (da) 1997-11-20 1998-11-20 Fremgangsmåde til DNA-afgivelse in vivo ved anvendelse af et nålefrit apparatur

Country Status (9)

Country Link
EP (1) EP1032429B1 (da)
AT (1) ATE241387T1 (da)
AU (1) AU753976B2 (da)
CA (1) CA2310029A1 (da)
DE (1) DE69815144T2 (da)
DK (1) DK1032429T3 (da)
ES (1) ES2198780T3 (da)
PT (1) PT1032429E (da)
WO (1) WO1999026662A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
AU3755800A (en) * 1999-03-15 2000-10-04 Introgen Therapeutics, Inc. Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses
WO2006124700A2 (en) 2005-05-12 2006-11-23 Introgen Therapeutics, Inc. P53 vaccines for the treatment of cancers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641190B3 (fr) * 1989-01-05 1991-09-20 Akra Injecteur sans aiguille
TW404844B (en) * 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe

Also Published As

Publication number Publication date
AU753976B2 (en) 2002-10-31
WO1999026662A1 (en) 1999-06-03
EP1032429A1 (en) 2000-09-06
DE69815144T2 (de) 2004-04-01
ES2198780T3 (es) 2004-02-01
PT1032429E (pt) 2003-10-31
AU1757999A (en) 1999-06-15
ATE241387T1 (de) 2003-06-15
CA2310029A1 (en) 1999-06-03
DE69815144D1 (de) 2003-07-03
EP1032429B1 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
DE69835085D1 (de) Regulation der transcription in säugetierzellen und viraler replikation durch eine tetracyclinrepressor
DE69630890D1 (de) Peptid-immitierende substanzen in der krebstherapie
HUP0002095A2 (hu) Vegyületek prosztatarák immunterápiás kezelésére és alkalmazásuk
ATE282434T1 (de) Eine zusammensetzung enthaltend eine detergenz und einen ein tumorsuppressorgen kodierenden, adenoviralen vektor
ATE143265T1 (de) Verfahren und zubereitungen zur krebsbehandlung mit oligonukleotiden
DK85786D0 (da) Biologisk aktive fragmenter af human antihaemofilisk faktor og fremgangsmaade til fremstilling deraf
EP1927660A3 (en) Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions
FI955552A0 (fi) Adenoviraalisia eläinperäisiä vektoreita ja niiden käyttö geeniterapiassa
DE69703689T2 (de) Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia
RU2007142645A (ru) Способ лечения или профилактики рака посредством использования композиций, содержащих альфа-2-макроглобулин
NO20013701D0 (no) HER-2/neu-fusjonsproteiner
ATE461707T1 (de) Pharmazeutische verbindung und methoden zur behandlungen von menschliche karzinome mittels arginin entzug
DE69431046D1 (de) Rekombinante adenoviren und deren verwendung in der gentherapie zur behandlung von augenerkrankungen
ATE226094T1 (de) Verfahren zur arzneistoffabgabe mittels gentherapie
DE60036105D1 (de) Herpes-simplex virus, das das gen von interleukin-12 exprimiert, und dessen verwendung zur behandlung von krebs
ES2114615T3 (es) Nueva sonda para el diagnostico de tumores o la terapia de tumores.
DK1032429T3 (da) Fremgangsmåde til DNA-afgivelse in vivo ved anvendelse af et nålefrit apparatur
BR9707994A (pt) Adenovírus recombinantes defectivo composição farmacêutica utilização do adenovirus composição e processo de preparação de células t citotóxicas especificas de um antigene tumoral
HUP0002913A2 (hu) Eljárások és készítmények szekretált fehérjéket, például béta-interferont kódoló géneket alkalmazó terápiára
Hu et al. A transient photoactivation of epidermal stem cells by femtosecond laser promotes skin wound healing
DE59510829D1 (de) Gentherapeutisches verfahren unter verwendung von dna-vektoren ohne selektionsmarker-gen
ES2147200T3 (es) Uso de un veneno de himenopteros para la fabricacion de un medicamento para tratar infecciones por virus de adn.
Norton et al. Expression of secreted platelet-derived growth factor-B by recombinant nonreplicating and noncytopathic vaccinia virus
DE60030850D1 (de) Verfahren zur behandlung von tumoren mittels antiangiogener substanzen
FI964784A0 (fi) Yhdistelmä-DNA-viruksia, valmistus ja käyttö geeniterapiassa